Published in Acta Neuropathol on January 01, 1972
Neurofilament gene expression: a major determinant of axonal caliber. Proc Natl Acad Sci U S A (1987) 2.36
Investigation of peripheral neuropathy. J Neurol Neurosurg Psychiatry (1995) 1.94
Giant axonal neuropathy-associated gigaxonin mutations impair intermediate filament protein degradation. J Clin Invest (2013) 1.79
Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone. J Neurol Neurosurg Psychiatry (1975) 1.21
Reorganization of axoplasmic organelles following beta, beta'-iminodipropionitrile administration. J Cell Biol (1981) 1.19
Modest loss of peripheral axons, muscle atrophy and formation of brain inclusions in mice with targeted deletion of gigaxonin exon 1. J Neurochem (2008) 1.18
Generalized giant axonal neuropathy: a filament-forming disease of neuronal, endothelial, glial, and schwann cells in a patient without kinky hair. Acta Neuropathol (1977) 1.16
Giant axonal neuropathy: clinical and genetic study in six cases. J Neurol Neurosurg Psychiatry (2005) 1.10
Selective presence of ubiquitin in intracellular inclusions. Am J Pathol (1989) 1.07
Gigaxonin controls vimentin organization through a tubulin chaperone-independent pathway. Hum Mol Genet (2009) 1.04
Giant axonal neuropathy. Involvement of peripheral nerve, myenteric plexus and extra-neuronal area. Acta Neuropathol (1977) 1.02
Giant axonal neuropathy: a conditional mutation affecting cytoskeletal organization. J Cell Biol (1985) 1.00
Giant axonal neuropathy. A neuropathological study. Acta Neuropathol (1987) 1.00
Infantile chronic peripheral neuropathy with giant axons. Report of a case. Acta Neuropathol (1977) 0.95
Sensory-motor deficits and neurofilament disorganization in gigaxonin-null mice. Mol Neurodegener (2011) 0.92
In vitro evidence that covalent crosslinking of neurofilaments occurs in gamma-diketone neuropathy. Proc Natl Acad Sci U S A (1984) 0.89
New mutations, genotype phenotype studies and manifesting carriers in giant axonal neuropathy. J Neurol Neurosurg Psychiatry (2007) 0.88
Pathology of skeletal muscle and intramuscular nerves in infantile neuroaxonal dystrophy. Acta Neuropathol (1986) 0.85
Giant axonal neuropathy: normal protein composition of neurofilaments. J Neurol Neurosurg Psychiatry (1983) 0.85
Giant axonal neuropathy: observations on a further patient. J Neurol Neurosurg Psychiatry (1988) 0.84
Genome-wide screen identifies drug-induced regulation of the gene giant axonal neuropathy (Gan) in a mouse model of antiretroviral-induced painful peripheral neuropathy. Biol Res Nurs (2009) 0.83
Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy. PLoS One (2015) 0.83
Giant axonal neuropathy: acceleration of neurofilament transport in optic axons. Proc Natl Acad Sci U S A (1985) 0.83
Ultrastructure of carbon disulphie neuropathy. Acta Neuropathol (1984) 0.83
Ultrastructural study of peripheral nerve in arteritic diabetic patients. Acta Neuropathol (1983) 0.82
Myenteric plexus neuropathy in infantile hypertrophic pyloric stenosis. Acta Neuropathol (1989) 0.81
Intermediate filament protein accumulation in motor neurons derived from giant axonal neuropathy iPSCs rescued by restoration of gigaxonin. Hum Mol Genet (2014) 0.81
The instability of the BTB-KELCH protein Gigaxonin causes Giant Axonal Neuropathy and constitutes a new penetrant and specific diagnostic test. Acta Neuropathol Commun (2014) 0.80
A review of gigaxonin mutations in giant axonal neuropathy (GAN) and cancer. Hum Genet (2016) 0.80
Charcot-marie-tooth disease: seventeen causative genes. J Clin Neurol (2006) 0.80
The central nervous system in canine giant axonal neuropathy. Acta Neuropathol (1979) 0.79
Abnormal intermediate filament organization alters mitochondrial motility in giant axonal neuropathy fibroblasts. Mol Biol Cell (2015) 0.78
Giant axonal neuropathy: report on a case with focal fiber loss. Acta Neuropathol (1992) 0.78
Optic nerve crush induces spatial and temporal gene expression patterns in retina and optic nerve of BALB/cJ mice. Mol Neurodegener (2014) 0.78
Axonal swellings in cerebellar white matter of groggy mutant rat. Acta Neuropathol (1995) 0.76
Giant axonopathy in streptozotocin diabetes of rats. Acta Neuropathol (1993) 0.76
The role of gigaxonin in the degradation of the glial-specific intermediate filament protein GFAP. Mol Biol Cell (2016) 0.75
Intermediate filament aggregates cause mitochondrial dysmotility and increase energy demands in giant axonal neuropathy. Hum Mol Genet (2016) 0.75
Giant axonal neuropathy: possibly secondary to vitamin b12 malabsorption. Acta Neuropathol (1977) 0.75
Novel homozygous missense mutation in GAN associated with Charcot-Marie-Tooth disease type 2 in a large consanguineous family from Israel. BMC Med Genet (2016) 0.75
Effects of mitotic spindle inhibitors on neurotubules and neurofilaments in anterior horn cells. J Cell Biol (1968) 4.65
Neurofibrillary pathology. J Neuropathol Exp Neurol (1970) 2.70
AN ELECTRON MICROSCOPIC STUDY OF DYSTROPHIC AXONS IN THE GRACILE AND CUNEATE NUCLEI OF VITAMIN E-DEFICIENT RATS. J Neuropathol Exp Neurol (1964) 2.53
Proximal axonal enlargement in motor neuron disease. Neurology (1968) 2.48
Experimental colchicine encephalopathy. I. Induction of neurofibrillary degeneration. Lab Invest (1967) 2.40
Intraneuronal conglomerates in sporadic motor neuron disease. A light and electron microscopic study. Arch Neurol (1969) 2.06
The pathogenesis of dying-back polyneuropathies. II. An ultrastructural study of experimental acrylamide intoxication in the cat. J Neuropathol Exp Neurol (1969) 1.93
Hypertrophic neuropathy. Q J Med (1967) 1.72
An electron microscopic study of hypertrophic neuropathy of Dejerine and Sottas. J Neurol Neurosurg Psychiatry (1967) 1.72
Peripheral nerve biopsy as an aid to diagnosis in infantile neuroaxonal dystrophy. Neurology (1970) 1.32
Infantile neuroaxonal dystrophy. Clinical, pathologic, and histochemical findings in a family with 3 affected siblings. Neurology (1967) 1.30
Neurofibrillary degeneration induced by vincristine therapy. Arch Neurol (1969) 1.27
The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci (1970) 1.26
Neuronal fibrous protein in human pathology. J Neuropathol Exp Neurol (1971) 1.20
Analysis of the process of sheath expansion in swollen nerve fibers. Brain Res (1970) 1.19
Neurofibrillary tangles induced by vincristine and vinblastine sulfate in central and peripheral neurons in vitro. Exp Neurol (1968) 1.03
Neurofilaments and glial filaments. Tissue Cell (1970) 0.97
The neuromyopathy of vincristine in the guinea pig. An electrophysiological and pathological study. J Neurol Sci (1970) 0.96
A note on the selective toxicity of vincristine sulfate on chick-embryo sensory ganglia in tissue culture. J Natl Cancer Inst (1966) 0.83
Recovery of herpes-simplex virus from human trigeminal ganglions. N Engl J Med (1973) 5.66
Type-common and type-specific monoclonal antibody to herpes simplex virus type 1. Infect Immun (1980) 5.03
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine (Baltimore) (1969) 4.72
Recovery of herpes simplex virus from human sacral ganglions. N Engl J Med (1974) 4.49
Theiler's virus persists in glial cells during demyelinating disease. Cell (1981) 2.67
Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain (1995) 2.61
Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol (1981) 2.53
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
Patterns of Guillain-Barre syndrome in children: results from a Mexican population. Neurology (2007) 2.32
Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect Immun (1983) 2.21
The role of Schwann cells in the formation of "onion bulbs" found in chronic neuropathies. J Neuropathol Exp Neurol (1967) 2.13
Glue-sniffing neuropathy. Arch Neurol (1975) 1.99
Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain (1970) 1.96
Creutzfeldt-Jakob disease in a young adult with idiopathic hypopituitarism. Possible relation to the administration of cadaveric human growth hormone. N Engl J Med (1985) 1.92
Pathology of the motor-sensory axonal Guillain-Barré syndrome. Ann Neurol (1996) 1.85
Guillain-Barré syndrome and Hodgkin's disease: three cases with immunological studies. Ann Neurol (1977) 1.84
HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol (1991) 1.81
The structural polypeptides of RNA slow viruses. Virology (1974) 1.81
Painful diabetic neuropathy. A morphometric study. Arch Neurol (1976) 1.77
Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc (1969) 1.74
Encephalopathy and peripheral neuropathy following diethylene glycol ingestion. Neurology (2005) 1.73
Multifocal demyelinating neuropathy with persistent conduction block. Neurology (1982) 1.69
Experimental herpes simplex encephalitis: early neuropathologic changes. J Neuropathol Exp Neurol (1970) 1.65
Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol (1996) 1.59
Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infect Immun (1979) 1.58
Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain (1975) 1.56
Giant axonal neuropathy. Pediatrics (1972) 1.53
Herpes simplex virus infection of nervous tissue in animals and man. Prog Med Virol (1975) 1.52
Early nodal changes in the acute motor axonal neuropathy pattern of the Guillain-Barré syndrome. J Neurocytol (1996) 1.51
Sensory perineuritis. Arch Neurol (1972) 1.51
Ischemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol (1968) 1.50
The acute sensory neuronopathy syndrome: a distinct clinical entity. Ann Neurol (1980) 1.47
On national needs for neurologists in the United States. Neurology (1986) 1.44
Acquired toxoplasmosis. A neglected cause of treatable nervous system disease. Arch Neurol (1975) 1.44
Diabetic neuropathy. Ann Neurol (1984) 1.44
Idiopathic polyneuritis after surgery. Arch Neurol (1968) 1.43
Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization. Lab Invest (1981) 1.43
Physiologic-pathologic correlation in Guillain-Barré syndrome in children. Neurology (2000) 1.43
Partial purification and evidence for multiple molecular forms of the scrapie agent. Biochemistry (1978) 1.42
Schwann cell proliferation in developing mouse sciatic nerve. A radioautographic study. J Cell Biol (1967) 1.41
Molecular population genetic analysis of Campylobacter jejuni HS:19 associated with Guillain-Barré syndrome and gastroenteritis. J Infect Dis (2001) 1.40
Duration of synthesis phase in neuilemma cells in mouse sciatic nerve during degeneration. Exp Neurol (1970) 1.34
Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol (1996) 1.34
Cervical internal carotid artery dissecting hemorrhage: diagnosis using MR. Radiology (1986) 1.32
Pathogenesis of lead encephalopathy. Uptake of lead and reaction of brain capillaries. Arch Neurol (1974) 1.31
An acute syndrome of ocular oscillations and truncal myoclonus. Brain (1968) 1.31
Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. N Engl J Med (1968) 1.30
Nonoperative treatment of brain abscesses in selected high-risk patients. J Neurosurg (1980) 1.30
Tubular aggregates in endoplasmic reticulum in herpes-simplex encephalitis. N Engl J Med (1971) 1.29
Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol (1999) 1.28
Progressive rubella panencephalitis. Late onset after congenital rubella. N Engl J Med (1975) 1.28
Chronic hypoventilation of central origin. A case with encephalitis lethargica and Parkinson's syndrome. Am Rev Respir Dis (1967) 1.28
Mitochondrial disorders: analysis of their clinical and imaging characteristics. AJNR Am J Neuroradiol (1993) 1.27
Antiserum-mediated demyelination in vivo: a sequential study using intraneural injection of experimental allergic neuritis serum. Lab Invest (1978) 1.25
Tubular aggregates in endoplasmic reticulum: evidence against their viral nature. J Ultrastruct Res (1972) 1.23
Hereditary sensory neuropathy. A clinical and ultrastructural study. J Neurol Sci (1970) 1.22
Virus-like particles and nucleoprotein-type filaments in brain tissue from two patients with Creutzfeldt-Jakob disease. Lancet (1970) 1.21
Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve (2009) 1.19
The numb chin in metastatic cancer. West J Med (1991) 1.16
Distal neuropathy in experimental diabetes mellitus. Ann Neurol (1980) 1.15
Brain stem tumors of childhood and adolescence. Am J Dis Child (1970) 1.15
Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome: molecular mimicry and host susceptibility. Neurology (1998) 1.14
Renaut bodies. A forgotten endoneurial structure. J Neuropathol Exp Neurol (1973) 1.14
Pain due to peripheral nerve damage: an hypothesis. Neurology (1984) 1.14
Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials. J Neurol Sci (2001) 1.10
Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve (2009) 1.09
Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment. Ann Neurol (1983) 1.08
Radioimmunoassay of herpes simplex virus antibody: correlation with ganglionic infection. J Gen Virol (1977) 1.07
Neurologists in the United States--past, present, and future. Neurology (1986) 1.07
Persistent herpes simplex virus infection in rabbit trigeminal ganglia. Lab Invest (1974) 1.05
Ataxic hemiparesis from a midbrain mass. Ann Neurol (1981) 1.05
The significance of giant vacuolation of endoneurial fibroblasts. Acta Neuropathol (1971) 1.05
Intra-axonal bacilli in lepromatous leprosy. A light and electron microscopic study. Acta Neuropathol (1974) 1.04
Distal symmetrical polyneuropathy: definition for clinical research. Muscle Nerve (2005) 1.04
Progressive hemifacial atrophy: report of three cases, including one observed over 43 years, and computed tomographic findings. Arch Neurol (1982) 1.04
Ultrastructure of mumps virus replication in newborn hamster central nervous system. Lab Invest (1974) 1.04
Comparison of clinical couse and sequential electrophysiological tests in diabetics with symptomatic polyneuropathy and its implications for clinical trials. Diabetes (1981) 1.04
The neuropathology of progressive rubella panencephalitis of late onset. Brain (1976) 1.04
Physiological responses of free-swimming adult coho salmon to simulated predator and fisheries encounters. Physiol Biochem Zool (2010) 1.03
Acute intermittent porphyria. Increased ALA-synthetase activity during an acute attack. Brain (1970) 1.03
Intracranial meningiomas in childhood and adolescence. Neurology (1972) 1.03
Pupil-involving third-nerve palsy and carotid stenosis: rapid recovery following endarterectomy. Ann Neurol (1997) 1.02
Experimental scrapie in mice: ultrastructural observations. Ann Neurol (1978) 1.02
In vivo demyelinating activity of sera from patients with Guillain-Barré syndrome. Ann Neurol (1982) 1.02
Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann Neurol (1982) 1.00
Giant axonal neuropathy. A neuropathological study. Acta Neuropathol (1987) 1.00
Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States. J Infect Dis (1999) 0.99
Herpetic proctitis and meningitis: recovery of two strains of herpes simplex virus type 1 from cerebrospinal fluid. J Infect Dis (1982) 0.99
Patterns of recovery in the Guillain-Barre syndromes. Neurology (1997) 0.99
Proximal diabetic neuropathy. Ann Neurol (1977) 0.99
Dural sinus thrombosis: study using intermediate field strength MR imaging. Radiology (1986) 0.97
Neuropathologic effects of proton-beam irradiation in man. I. Dose-response relationships after treatment of intracranial neoplasms. Acta Neuropathol (1972) 0.97